SVA

Sinovac Biotech, Ltd.

$6.47

Market Neutral — Building

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

—

Edge

—

Is SVA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2026-10-22 → 2026-10-22

S? 1w

2026-10-222026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 1w current

Total tracked: 0 weeks across 1 stage run.

vs 52W High

—

Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.

Stage Maturity

Week 1

1w13w26w

Week 1, fresh breakout

How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.

vs 200 DMA

—

Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.

Rel Volume

—

vs 50-day avg

Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.

Trend Health

—

Not enough history yet

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

—

YTD

—

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S—

Wk 1 · Vol —x

Moving averages & range

50 DMA

—

200 DMA

—

52W High

—

52W Low

—

5D Low

—

Resistance levels (recent highs)

20d High

—

60d High

—

120d High

—

250d High

—

Next resistance

Above all

P/E (TTM)

6.7

Forward -53.9

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.